Dr Reddy's Laboratories Ltd

RDY

Company Profile

  • Business description

    Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

  • Contact

    8-2-337, Road No. 3
    Banjara Hills
    HyderabadTG500 034
    IND

    T: +91 4049002900

    E: [email protected]

    https://www.drreddys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    27,811

Stocks News & Analysis

stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.
stocks

AMD and OpenAI partnership

What does another huge AI deal mean for investors?
stocks

Undervalued ASX founder-led companies

Can this strategy pick the winners?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,253.6025.70-0.28%
CAC 407,974.853.070.04%
DAX 4024,385.787.490.03%
Dow JONES (US)46,602.9891.99-0.20%
FTSE 1009,483.584.440.05%
HKSE26,957.77183.15-0.67%
NASDAQ22,788.36153.30-0.67%
Nikkei 22547,950.886.120.01%
NZX 50 Index13,531.2942.050.31%
S&P 5006,714.5925.69-0.38%
S&P/ASX 2008,956.8019.10-0.21%
SSE Composite Index3,882.7820.250.52%

Market Movers